Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment
NCT00932867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3114
Last updated 2010-04-20
Summary
Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
Conditions
Interventions
- DRUG
-
Kinzal/Pritor (Telmisartan, BAY68-9291)
Patients under daily life treatment receiving Pritor according to local drug information.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2008-06-30
- Completion
- 2009-08-31
Countries
- Romania
- Slovakia
More Related Trials
-
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
NCT00366119 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
NCT00153101 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.
NCT06625346 ·Status: RECRUITING
-
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
NCT00946829 ·Status: COMPLETED
-
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
NCT00160160 ·Status: COMPLETED ·Phase: NA
-
Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure
NCT03255551 ·Status: COMPLETED
-
Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
NCT00208221 ·Status: TERMINATED ·Phase: PHASE3
-
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
NCT00095290 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
NCT00863980 ·Status: TERMINATED ·Phase: NA
-
BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
NCT03991442 ·Status: COMPLETED ·Phase: PHASE3
-
Essential Hypertension
NCT01264692 ·Status: COMPLETED ·Phase: PHASE2
-
Irbesartan and Atenolol in Hypertensive Heart Disease
NCT00389168 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan
NCT03217825 ·Status: COMPLETED ·Phase: PHASE2
-
Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension
NCT03626259 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate ALN-AGT01 in Patients With Hypertension
NCT03934307 ·Status: COMPLETED ·Phase: PHASE1
-
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
NCT00095394 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
NCT02085265 ·Status: TERMINATED ·Phase: PHASE2
-
Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5
NCT00239369 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
NCT07030101 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension
NCT03021265 ·Status: COMPLETED
-
S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
NCT03226340 ·Status: UNKNOWN ·Phase: PHASE4
-
Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations
NCT01320397 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
NCT02269176 ·Status: COMPLETED ·Phase: PHASE3
-
Ramipril 10 mg/Day Prevention
NCT01053910 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
NCT03639480 ·Status: UNKNOWN ·Phase: PHASE3